Positions

Overview

  • From 2004-10 Dr. Rich was UAB Senior Vice President for Medicine and Dean of the School of Medicine and from 2004-16 served as Professor of Medicine, Microbiology and (since 2012) Medical Education. From 2011-14 he was Faculty Accreditation Lead for reaccreditation of the School of Medicine. From 2014-16 he developed and then served as founding Director of the university-wide UAB Center for Interprofessional Education and Simulation. Dr. Rich was a member of the faculty of Baylor College of Medicine from 1973-98 and from 1990-98 he also served as Vice President and Dean of Research at Baylor. He was an Investigator of the Howard Hughes Medical Institute from 1977-91 and from 1998-04 he was Executive Associate Dean for Research and Strategic Initiatives at Emory University School of Medicine.

    From 2003-08 Dr. Rich was Editor-in-Chief of The Journal of Immunology. Other appointments to editorial boards have included The Journal of Experimental Medicine, The Journal of Infectious Diseases, The Journal of Clinical Immunology and Clinical and Experimental Immunology. He is also the founding Editor-in-Chief of a comprehensive textbook Clinical Immunology: Principles and Practice; the 5th edition of the book is scheduled for publication in 2018. He has authored or co-authored more than 200 articles and chapters in scientific journals and books. His research focused on cellular and molecular interactions between antigen presenting cells and T lymphocytes, including definition of interactions of superantigens with T cell receptors for antigen and discovery of the molecular basis of peptide binding and functional specialization of a major histocompatibility class Ib molecule.

    Dr. Rich is Past President and Past Chairman of the Board of Directors of the Federation of American Societies for Experimental Biology. He is also Past President of the Clinical Immunology Society. He was Vice President of the American Academy of Allergy Asthma and Immunology, Chair of its Professional Education Council, Chair of the Basic and Clinical Immunology Interest Section and a member of its Board of Directors. He served as a member of two NIH Study Sections (as chair of one) and on the Boards of Directors of the American Board of Allergy and Immunology (also as chair) and the American Board of Internal Medicine. He was a Councilor of the American Clinical and Climatological Association and a member of the Council of the American Association of Immunologists, for which he also chaired the committees on Clinical Immunology and Public Affairs.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2006 From whence we come (happy birthday to us)Journal of Immunology.  176:2031-2032. 2006
    2004 Rediscovering the pillarsJournal of Immunology.  173:1. 2004
    2003 Cotton rat Sihi-M3 is a minimally oligomorphic Mhc I-b molecule that binds the chemotactic peptide fMLF under stringent conditions: Evidence that positive selection drives inter-species diversity of residues interacting with the termini of short peptidesImmunogenetics.  55:389-394. 2003
    2003 Hyperconservation of the N-formyl peptide binding site of M3: Evidence that M3 is an old eutherian molecule with conserved recognition of a pathogen-associated molecular patternJournal of Immunology.  171:836-844. 2003
    2003 Benefit versus riskJournal of Immunology.  170:2793. 2003
    2003 The baton is passedJournal of Immunology.  170:1-2. 2003
    2002 Hyperconservation of the putative antigen recognition site of the MHC class I-b molecule TL in the subfamily murinae: Evidence that thymus leukemia antigen is an ancient mammalian geneJournal of Immunology.  169:6890-6899. 2002
    2002 Science policy: The NIH budget in the "Postdoubling" eraScience.  296:1401-1402. 2002
    2001 Involvement of Hematopoietic Progenitor Kinase 1 in T Cell Receptor SignalingJournal of Biological Chemistry.  276:18908-18914. 2001
    2001 Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I moleculesEuropean Journal of Immunology.  31:1181-1190. 2001
    2001 Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules.European Journal of Immunology.  31:1181-1190. 2001
    2001 Superantigen recognition by γδ T cells: SEA recognition site for human Vγ2 T cell receptorsImmunity.  14:331-344. 2001
    2000 Heterogeneity of RAMA-S cell line: Derivatives of RAMA-S cells lacking H2-Kb and H2-Db expressionImmunogenetics.  52:150-154. 2000
    2000 Immunization with f-Met peptides induces immune reactivity against Mycobacterium tuberculosisTubercle and Lung Disease.  80:5-13. 2000
    1998 Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and nonresponder vaccine recipientsHuman Immunology.  59:783-793. 1998
    1998 Structural dichotomy of Staphylococcal enterotoxin C superantigens leading to MHC class II-independent activation of T lymphocytesJournal of Immunology.  160:2107-2114. 1998
    1998 Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting moleculeJournal of Immunology.  160:615-623. 1998
    1998 The future of allergy practice: An academician's perspectiveAllergy and Asthma Proceedings.  19:295-299. 1998
    1996 Altered Orientation of Streptococcal Superantigen (SSA) on HLA-DR1 Allows Unconventional Regions to Contribute to SSA Vβ SpecificityJournal of Immunology.  157:4970-4978. 1996
    1996 Chimeric β2m·h-2m3 single chain: a model for studying the functions of an mhc class i-b moleculeFederation proceedings.  10. 1996
    1996 MHC class IB molecule, Qa-1b, presents a proteinaseresistant hydrophobic antigen from mycobacteriaFederation proceedings.  10. 1996
    1996 Transplantation of the n-formyl pocket of H-2M3 to K bFederation proceedings.  10. 1996
    1996 Species-Dependent Post-Translational Modification and Position 2 Allelism: Effects on Streptococcal Superantigen SSA Structure and Vβ SpecificityJournal of Immunology.  157:2479-2487. 1996
    1996 Phylogenetic distribution of streptococcal superantigen SSA allelic variants provides evidence for horizontal transfer of ssa within Streptococcus pyogenesInfection and Immunity.  64:1161-1165. 1996
    1996 Residues near the amino and carboxyl termini of staphylococcal enterotoxin E independently mediate TCR Vβ-specific interactionsJournal of Immunology.  156:2178-2185. 1996
    1996 Justifying a mechanism-based specialty.Journal of Allergy and Clinical Immunology.  97:868-871. 1996
    1996 Practice parameters for the diagnosis and management of immunodeficiency. The Clinical and Laboratory Immunology Committee of the American Academy of Allergy, Asthma, and Immunology (CLIC-AAAAI)Annals of Allergy, Asthma and Immunology.  76:282-294. 1996
    1996 H2-M3wt-restricted, Listeria monocytogenes-specific CD8 T cells recognize a novel, hydrophobic, protease-resistant, periodate-sensitive antigenInternational Immunology.  8:367-378. 1996
    1996 Major histocompatibility complex class ii-independent presentation of staphylococcal enterotoxins to humant cellsJournal of Investigative Medicine.  44. 1996
    1996 N terminal allelism and species-dependent modification alter streptococcal superantigen vβ-specificityJournal of Investigative Medicine.  44. 1996
    1996 Practice parameters for the diagnosis and management of immunodeficiencyAnnals of Allergy, Asthma and Immunology.  76:282-294. 1996
    1995 H-2M3a violates the paradigm for major histoeompatibility complex class I peptide bindingJournal of Experimental Medicine.  181:1817-1825. 1995
    1995 Peptides from the amino-terminus of mouse mitochondrially encoded NADH dehydrogenase subunit 1 are potent chemoattractantsBiochemical and Biophysical Research Communications.  211:812-818. 1995
    1995 Whither clinical immunology?Journal of Immunology.  155:4992-4995. 1995
    1994 Characterization and distribution of insertion sequence IS1239 in Streptococcus pyogenesGene.  150:135-140. 1994
    1994 Antigen presentation by major histocompatibility complex class I-b moleculesAnnual Review of Immunology.  12:839-880. 1994
    1994 Availability of endogenous peptides limits expression of an M3a-Ld major histocompatibility complex class I chimeraJournal of Experimental Medicine.  179:155-165. 1994
    1994 Effect of CD28 signal transduction on c-Rel in human peripheral blood T cellsMolecular and Cellular Biology.  14:7933-7942. 1994
    1994 Health care reform: Implications for biomedical researchFederation proceedings.  8:799. 1994
    1994 Long-term inositol phosphate release, but not tyrosine kinase activity, correlates with IL-2 secretion and NF-AT induction in anti-CD3-activated peripheral human T lymphocytesCellular Immunology.  157:158-169. 1994
    1994 Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenesInfection and Immunity.  62:1867-1874. 1994
    1993 Differential amino-terminal anchors for peptide binding to H-2M3a or H-2Kb and H-2Db1Journal of Immunology.  151:201-210. 1993
    1993 Localization of a site on bacterial superantigens that determines T cell receptor β chain specificityJournal of Experimental Medicine.  177:283-293. 1993
    1993 A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and CJournal of Clinical Investigation.  92:710-719. 1993
    1993 Intravenous IgG: Supertherapy for superantigens?Journal of Clinical Investigation.  91:378. 1993
    1993 Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxinsInfection and Immunity.  61:3175-3183. 1993
    1992 Biochemical specificity of H-2M3a: Stereospecificity and space-filling requirements at position 1 maintain N-formyl peptide bindingJournal of Immunology.  149:3605-3611. 1992
    1992 Kinetics of killing by monoclonal cytotoxic T lymphocytes. I. Colorimetric detection of cryptic CTL determinants on adherent target cells and survivorship analysisJournal of Immunological Methods.  152:159-169. 1992
    1992 Dual roles for class II major histocompatibility complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicityInfection and Immunity.  60:5190-5196. 1992
    1992 Isolation and characterization of a novel streptococcal superantigen.Transactions of the Association of American Physicians.  105:110-122. 1992
    1992 Specialized role for a murine class I-b MHC molecule in prokaryotic host defensesScience.  257:678-679. 1992
    1991 Specialized function of the nonclassical MHC class I molecule Hmt: A specific receptor for N-formylated peptidesImmunologic Research.  10:365-375. 1991
    1991 Staphylococcal toxins bind to different sites on HLA-DRJournal of Immunology.  147:3876-3881. 1991
    1991 Specialized functions of major histocompatibility complex class i molecules. ii. hmt binds n-formylated peptides of mitochondrial and prokaryotic originJournal of Experimental Medicine.  174:941-944. 1991
    1991 Staphylococcal exotoxin activation of T cells: Role of exotoxin-MHC class II binding affinity and class II isotypeJournal of Immunology.  146:463-468. 1991
    1991 Distinct biochemical features of interferon gamma receptors on human T lymphocytesMolecular Immunology.  28:553-557. 1991
    1991 Molecular biology and immunology: An introductionJournal of Allergy and Clinical Immunology.  88:535-551. 1991
    1991 Mutation of the disulfide loop in staphylococcal enterotoxin A: Consequences for T cell recognitionJournal of Immunology.  147:3274-3281. 1991
    1991 Mutational analysis of regulation of MHC and anti-viral genesJournal of Immunology.  146:1979-1986. 1991
    1990 Dissociation of the Stimulatory Activities of Staphylococcal Enterotoxins for T Cells and MonocytesJournal of Experimental Medicine.  172:1831-1841. 1990
    1990 Specialized functions of MHC class i molecules: I. An n-formyl peptide receptor is required for construction of the class i antigen MtaJournal of Experimental Medicine.  171:897-912. 1990
    1990 MHC class II molecules transduce signals in monocytes in response to bound staphylococcal enterotoxins and toxic shock syndrome toxin.Transactions of the Association of American Physicians.  103:289-297. 1990
    1990 Retrovirus-Mediated Insertional Mutagenesis: Phagemid Rescue of Flanking DNA by Selecting Plasmid oriDNA (Mary Ann Liebert, Inc.).  9:139-147. 1990
    1990 The role of physical forces on cytotoxic T cell-target cell conjugate stabilityJournal of Immunology.  144:4129-4138. 1990
    1989 An unexpectedly labile mitochondrially encoded protein is required for Mta expressionImmunogenetics.  29:258-264. 1989
    1989 Class II MHC molecules are specific receptors for Staphylococcus enterotoxin AScience.  244:817-820. 1989
    1989 Prostaglandin E2 selectively increases interferon gamma receptor expression on human CD8+ lymphocytesJournal of Clinical Investigation.  83:1436-1440. 1989
    1989 Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules.Transactions- American Clinical and Climatological Association.  101. 1989
    1988 Induction of suppressor T cells by cytokinesTransplantation Proceedings.  20:1156-1157. 1988
    1988 Regulation of Qa-1 expression and determinant modification by an H-2D-linked gene, QdmImmunogenetics.  28:334-344. 1988
    1988 Polymorphic Bgl II restriction sites of DR α demarcate a novel HLA-DR1 antigenImmunogenetics.  28:171-181. 1988
    1988 Human immunodeficiency virus-induced pathology favored by cellular transmission and activationFederation proceedings.  2:251-255. 1988
    1988 Shear Stress Effects on Human T Cell FunctionBiotechnology Progress.  4:89-96. 1988
    1987 Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-γ-treated dermal fibroblastsJournal of Immunology.  139:715-723. 1987
    1987 Suppressor cell growth factor and anti-CD3 antibodies stimulate reciprocal subsets of T lymphocytesJournal of Experimental Medicine.  166:404-418. 1987
    1987 Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotypeTransplantation Proceedings.  19:851-857. 1987
    1987 Unglycosylated Mtaa expresses an Mtab-like determinantImmunogenetics.  25:234-240. 1987
    1987 Maternally transmitted antigens are codominantly expressed by mouse cells containing two kinds of mitochondrial DNAJournal of Experimental Medicine.  165:560-565. 1987
    1987 Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype.Transplantation Proceedings.  19:851-857. 1987
    1987 Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiencyJournal of Clinical Investigation.  80:998-1008. 1987
    1987 Differential antigen-presenting cell requirements of hapten-specific T cell lines restricted to class II determinantsJournal of Immunology.  138:2384-2391. 1987
    1987 Human suppressor T lymphocyte growth and differentiation.Transactions- American Clinical and Climatological Association.  99:32-40. 1987
    1987 Sequential effects of prostaglandins and interferon-γ on differentiation of CD8+suppressor cellsJournal of Immunology.  139:688-694. 1987
    1987 Trinitrophenyl reactive T-cell clones in functional and molecular analysis of the HLA-D region.Advances in Experimental Medicine and Biology.  225:43-54. 1987
    1986 Opposing immunoregulatory functions of CD8+lymphocytes: A requirement for monocytes in suppressor cell inductionJournal of Immunology.  137:2468-2477. 1986
    1986 Molecular characterization of a subtype of DQw1 recognized by hapten-specific T cellsImmunogenetics.  24:209-216. 1986
    1986 Clonal analysis of the anti-Qa-1 cytotoxic T lymphocyte repertoire: Definition of the Qa-1(d) and Qa-1(c) alloantigens and cross-reactivity with H-21Journal of Immunology.  136:383-388. 1986
    1986 Human suppressor T cells: Induction, differentiation, and regulatory functionsHuman Immunology.  17:369-387. 1986
    1986 Maternally Transmitted AntigenAdvances in Immunology.  38:313-359. 1986
    1986 Proliferative signals for suppressor T cells. Helper cells stimulated with pokeweed mitogen in vitro produce a suppressor cell growth factorJournal of Clinical Investigation.  78:214-220. 1986
    1986 Regulation of primary cytotoxic T lymphocyte responses generated during mixed leukocyte culture with H-2(d) identical Qa-1 disparate cellsJournal of Immunology.  137:1776-1781. 1986
    1985 Dissociation of proliferative and differentiative signals for human suppressor T cells.Transactions of the Association of American Physicians.  98:150-157. 1985
    1985 Multiparameter analysis of human lymphocyte subpopulations using flow cytometry.Survey and synthesis of pathology research.  4:237-247. 1985
    1985 Oligosaccharide-dependent and independent Qa-1 determinantsJournal of Immunology.  134:3218-3225. 1985
    1985 The Qa-1 alloantigens: III. Biochemical analysis of the structure and extent of polymorphism of the Qa-1 allelic productsJournal of Immunology.  135:1264-1270. 1985
    1985 Mitochondrial modulation of maternally transmitted antigen: Analysis of cell hybridsProceedings of the National Academy of Sciences.  82:3286-3290. 1985
    1985 Cellular requirements for the generation of primary cell-mediated lympholysis responses to Qa-1 antigensJournal of Immunology.  134:2198-2204. 1985
    1985 Polymorphism and tissue distribution of maternally transmitted antigen defined by cytotoxic T lymphocyte linesJournal of Immunology.  134:2191-2197. 1985
    1985 Analysis of the Qa-4 allodeterminantImmunogenetics.  21:511-516. 1985
    1985 Correlation of Qa-1 determinants defined by antisera and by cytotoxic T lymphocytesImmunogenetics.  21:215-225. 1985
    1985 Class II determinants recognized by TNP-specific cloned human T cell linesHuman Immunology.  14:59-76. 1985
    1985 Class II positive human dermal fibroblasts restimulate cloned allospecific T cells but fail to stimulate primary allogeneic lymphoproliferationHuman Immunology.  14:245-258. 1985
    1985 Cytotoxic T lymphocyte (CTL) definition of Qa-1 determinantsFederation proceedings.  44. 1985
    1985 Differential glycosylation requirements for the cell surface expression of class I moleculesJournal of Immunology.  134:423-430. 1985
    1985 Disproportionate expansion of a minor t cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndromeJournal of Infectious Diseases.  151:555-559. 1985
    1985 HLA restriction patterns of trinitrophenyl-specific proliferative human T cell clonesTransplantation Proceedings.  17:972-977. 1985
    1985 Ia expression and antigen presenting functions of cloned TNP-specific human T cell linesFederation proceedings.  44. 1985
    1985 Maternally transmitted antigen: Analysis by cloned cytotoxic T lymphocytesFederation proceedings.  44. 1985
    1985 Pokeweed mitogen activated helper cells produce a suppressor cell growth factorFederation proceedings.  44. 1985
    1985 The hla complex and the pathogenesis of infectious diseasesJournal of Infectious Diseases.  151:1-8. 1985
    1984 Lymphocyte subsets in patients with acquired immunodeficiency syndrome (AIDS), aids-related complex (ARC), and acute viral infections.Transactions of the Association of American Physicians.  97:197-204. 1984
    1984 Cellular requirements for induction of human primary proliferative responses to trinitrophenyl-modified cellsJournal of Immunology.  132:19-24. 1984
    1984 Biochemical characterization of the Qa-1 alloantigensFederation proceedings.  43. 1984
    1984 Cloned human T cells synthetize Ia molecules and can function as antigen presenting cellsHuman Immunology.  11:219-228. 1984
    1984 Regulatory interactions governing the proliferation of T cell subsets stimulated with pokeweed mitogenJournal of Immunology.  132:1106-1112. 1984
    1983 Mitochondria control expression of a murine cell surface antigenNature.  306:599-601. 1983
    1983 Differences in maternal lineages of new zealand black mice defined by restriction endonuclease analysis of mitochondrial dna and by expression of maternally transmitted antigenJournal of Experimental Medicine.  157:2154-2159. 1983
    1983 Cytotoxicity by NK-like cells from hepatitis B-immune patients to a human hepatoma cell line secreting HBsAgJournal of Immunology.  130:173-180. 1983
    1983 Antigen presentation to human T lymphocytes. II. Requirements for Mac-120+ macrophages and responsiveness to interleukin 2Cellular Immunology.  76:379-389. 1983
    1983 Characterization of determinants encoded by four Qa-1 genotypes and their recognition by cloned cytotoxic T lymphocytesJournal of Immunology.  131:2147-2153. 1983
    1983 T-T cell interactions in cell-mediated immune responses to major histocompatibility complex antigens.Critical Reviews in Immunology.  4:129-168. 1983
    1983 The Qa-1 alloantigens. II. Evidence for the expression of Qa-1 molecules by the Qa-1(d) genotype and for cross-reactivity between Qa-1 and H-2K(f)Journal of Immunology.  130:1293-1294. 1983
    1982 Primary cell-mediated lympholysis response to a maternally transmitted antigenJournal of Experimental Medicine.  156:1866-1871. 1982
    1982 Bromodeoxyuridine and light treatment enhances responsiveness of pokeweed mitogen-stimulated human lymphocytes to autologous and allogeneic determinantsCellular Immunology.  72:102-112. 1982
    1982 Qa-1-associated antigens: IV. Evidence for additional Qa-1 polymorphism defined biochemically and by cytotoxic T lymphocyte recognitionTransplantation.  34:54-59. 1982
    1981 Antigen presentation to human t lymphocytes: I. different requirements for stimulation by hapten-modified cells vs. cell sonicatesJournal of Experimental Medicine.  154:1005-1015. 1981
    1981 Divalent cations and cytochalasin B-sensitive processes in activation, synthesis, and release of mixed leukocyte reaction suppressor factorCellular Immunology.  61:353-364. 1981
    1981 Cellular and antigenic requirements for production of mixed leukocyte reaction suppressor factorJournal of Immunology.  127:2176-2182. 1981
    1981 Regulatory mechanisms in tumor immunity: introduction and summary.Federation proceedings.  40:36-38. 1981
    1981 Role of calcium and magnesium and of cytochalasin-sensitive processes in lectin-stimulated lymphocyte activationCellular Immunology.  59:276-288. 1981
    1981 The Qa-1 alloantigens. I. Identification and molecular weight characterization of glycoproteins controlled by the Qa-1(a) and Qa-1(b) allelesJournal of Immunology.  127:1894-1898. 1981
    1980 Qa-1-associated antigens. III. Distribution of Qa-1 region antigens on lymphoid subpopulationsJournal of Immunology.  125:2597-2603. 1980
    1980 Role of Ia-positive cells in induction of secondary human immune responses to haptens in vitroJournal of Experimental Medicine.  152:218-234. 1980
    1980 Role of Ia-positive cells in induction of secondary human immune responses to haptens in vitro.Journal of Experimental Medicine.  152:218s-234s. 1980
    1979 Interaction between T cells and non-T cells in suppression of cytotoxic lymphocyte responsesJournal of Immunology.  123:745-750. 1979
    1979 Primary in vitro cytotoxic response of nzb spleen cells to qa-lb-associated antigenic determinantsJournal of Experimental Medicine.  150:1555-1560. 1979
    1979 Requlation of cytotoxic lymphocyte responses in New Zealand mice by alloantigen-activated spleen cells.Journal of Immunology.  122:1476-1481. 1979
    1979 H-2-nonrestricted cytotoxic responses to an antigen encoded telomeric to H-2DJournal of Immunology.  122:196-201. 1979
    1979 Human immune responses to hapten-conjugated cells. II. The roles of autologous and allogeneic histocompatibility determinants in proliferative responses in vitroJournal of Immunology.  122:1828-1833. 1979
    1979 Physiology of mixed leukocyte reaction suppressor factor. I. Role of cytoskeleton and protein synthesis in production and secretionJournal of Immunology.  122:1022-1028. 1979
    1979 Prenatal diagnosis of congenital adrenal hyperplasiaAmerican Journal of Medical Genetics.  4:201-204. 1979
    1979 Qa-1-associated antigens. I. Generation of H-2-nonrestricted cytotoxic T lymphocytes specific for determinants of the Qa-1 regionJournal of Immunology.  123:1232-1238. 1979
    1979 Qa-1-associated antigens. II. Evidence for functional differentiation from H-2K and H-2D antigensJournal of Immunology.  123:1239-1244. 1979
    1979 Recognition of hapten-modified cells in vitro by human T lymphocytesJournal of Clinical Investigation.  64:967-976. 1979
    1979 Regulation of cytotoxic lymphocyte responses in New Zealand mice by alloantigen-activated spleen cellsJournal of Immunology.  122:1476-1481. 1979
    1979 Regulatory mechanisms in cell-mediated immune responses: VII. Presence of I-C subregion determinants on mixed leukocyte reaction suppressor factor*Journal of Experimental Medicine.  149:114-126. 1979
    1978 Regulation of alloantigen-induced cytotoxic responses by concanavalin A-activated lymphoid cells: suppression by antigen eliminationJournal of Immunology.  121:1732-1737. 1978
    1978 Suppression of cytotoxic lymphocyte responses in vitro by soluble products of alloantigen-activated spleen cellsJournal of Immunology.  121:1045-1051. 1978
    1978 Suppressor factor activity in cell mediated immune responsesJournal of the Reticuloendothelial Society.  24:417-425. 1978
    1978 Human immune responses to hapten-conjugated cells: I. Primary and secondary proliferative responses in vitro*Journal of Experimental Medicine.  147:1671-1683. 1978
    1978 Mechanism of suppression of alloantigen-induced cytotoxic responses by concanavalin A-activated lymphoid cellsFederation proceedings.  37. 1978
    1978 Suppressor T cells in the regulation of immune responses to allogeneic tissuesTransplantation Proceedings.  10:19-22. 1978
    1977 Regulation of cytotoxic lymphocyte responses in vitro by alloantigen activated spleen cellsJournal of Immunology.  119:31-37. 1977
    1977 Regulatory mechanisms in cell-mediated immune responses: VI. Interaction of H-2 and Non-H-2 genes in elaboration of mixed leukocyte reaction suppressor factor*Journal of Experimental Medicine.  146:1221-1233. 1977
    1977 Regulatory mechanisms in cell-mediated immune responses: V. H-2 homology requirements for the production of a minor locus-induced suppressor factor*Journal of Experimental Medicine.  146:1152-1157. 1977
    1977 Aspirin and Delayed Type HypersensitivityArthritis and Rheumatism.  20:1174-1178. 1977
    1977 Fractionation of lymphocyte subpopulations which regulate mixed lymphocyte reactionsJournal of Immunology.  118:1252-1258. 1977
    1977 Migratory properties of normal lymphoid cells with different concanavalin A-binding capacitiesClinical immunology and immunopathology.  8:300-310. 1977
    1977 Modulation of immunity by thymus-derived lymphocytesPharmacology and Therapeutics.  2:113-137. 1977
    1976 Regulatory mechanisms in cell-mediated immune responses: IV. Expression of a receptor for mixed lymphocyte reaction suppressor factor on activated T lymphocytes*Journal of Experimental Medicine.  144:1214-1226. 1976
    1976 Suppression of mixed lymphocyte reactions by alloantigen-activated spleen-localizing thymocytesCellular Immunology.  22:358-368. 1976
    1976 Regulatory mechanisms in cell-mediated immune responses: III. I-region control of suppressor cell interaction with responder cells in mixed lymphocyte reactions*Journal of Experimental Medicine.  143:672-677. 1976
    1976 Biological expression of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A activated spleen cellsJournal of Immunology.  117:323-330. 1976
    1976 Immune mechanisms in systemic lupus erythematosus.Perspectives in nephrology and hypertension.  3:3-11. 1976
    1975 Biological expressions of lymphocyte activation. IV. Concanavalin A activated suppressor cells in mouse mixed lymphocyte reactionsJournal of Immunology.  114:1112-1115. 1975
    1975 Determinants of differential migration of mouse spleen cells treated with Concanavalin AJournal of Immunology.  115:771-776. 1975
    1975 Regulatory mechanisms in cell mediated immune responses. II. A genetically restricted suppressor of mixed lymphocyte reactions released by alloantigen activated spleen cellsJournal of Experimental Medicine.  142:1391-1402. 1975
    1975 Antibody synthesis and immunological memory in concanavalin A-treated miceClinical immunology and immunopathology.  3:482-491. 1975
    1975 Determinants of differential migration of concanavalin A activated lymphocytesFederation proceedings.  34. 1975
    1975 Migration and activation of regulatory T cells for mouse mixed lymphocyte reactionsFederation proceedings.  34. 1975
    1975 Scanning electron microscopy of normal and mitogen-stimulated mouse lymphoid cellsCellular Immunology.  19:336-348. 1975
    1975 Suppression of mixed lymphocyte reaction by factors released from alloantigen activated spleen cellsFederation proceedings.  34:4635. 1975
    1974 Regulatory mechanisms in cell-mediated immune responses: I. Regulation of mixed lymphocyte reactions by alloantigen-activated thymus-derived lymphocytesJournal of Experimental Medicine.  140:1588-1603. 1974
    1974 Biological expressions of lymphocyte activation. III. Suppression of plaque forming cell responses in vitro by supernatant fluids from concanavalin A activated spleen cell culturesJournal of Immunology.  112:1360-1368. 1974
    1974 Concanavalin A induced modulation of antibody synthesis in vivoFederation proceedings.  33:2889. 1974
    1974 Migration of concanavalin A activated lymphocytesFederation proceedings.  33. 1974
    1973 Immunological and clinical effects of transfer factor in anergic subjects.Advances in Experimental Medicine and Biology.  29:343-350. 1973
    1973 Therapy of sarcoidosis initiated with alternate day prednisoneJournal of the National Medical Association.  65:391-398. 1973
    1973 Biological expressions of lymphocyte activation: II. generation of a population of thymus-derived suppressor lymphocytesJournal of Experimental Medicine.  137:649-659. 1973
    1973 Biological expressions of lymphocyte activation: I. Effects of phytomitogens on antibody synthesis in vitroJournal of Experimental Medicine.  137:205-223. 1973
    1973 Mechanism of allergy to components of commercial bovine thyrotropinJournal of Allergy and Clinical Immunology.  51:296-302. 1973
    1973 Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritisArthritis and Rheumatism.  16:1-9. 1973
    1972 Effect of transfer factor on lymphocyte function in anergic patients.Journal of Clinical Investigation.  51:2948-2958. 1972
    1972 Simultaneous suppression of responses to allogeneic tissue in vitro and in vivoCellular Immunology.  5:190-200. 1972
    1971 Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution.Clinical and Experimental Immunology.  9:733-748. 1971
    1971 Chronic mucocutaneous candidiasis: model-building in cellular immunity.Annals of Internal Medicine.  74:955-978. 1971
    1971 Inhibition of growth of candida albicans by iron-unsaturated lactoferrin: Relation to host-defense mechanisms in chronic mucocutaneous candidiasisJournal of Infectious Diseases.  124:539-544. 1971
    1971 Photosensitive cheilitis. Clinical and pathogenetic considerations.Annals of Internal Medicine.  75:909-917. 1971
    1970 TREATMENT OF CHRONIC MONILIASIS WITH LYMPHOCYTE TRANSFUSIONSLancet.  296:569. 1970
    1965 Mesenchymal metaplasia of the chick chorioallantoic membrane; a non-specific response to selected stimuliExperimental Cell Research.  40:96-103. 1965

    Book

    Year Title Altmetric
    2012 Clinical immunology: Principles and practice: Fourth edition 2012
    2012 Preface to the first edition 2012
    2012 Preface to the fourth edition 2012
    2008 Clinical Immunology 2008
    2008 Preface to the first edition 2008
    2008 Preface to the third edition 2008
    2008 Clinical Immunology 2008

    Chapter

    Year Title Altmetric
    2012 Antigens and antigen presentation.  77-89. 2012
    2012 The human immune response.  3-13. 2012
    2008 Antigens and antigen processing.  91-101. 2008
    2008 The human immune response.  3-16. 2008

    Education And Training

  • Doctor of Medicine, University of Kansas School of Medicine 1966
  • Bachelor's Degree in Immunology, Oberlin College 1962
  • Full Name

  • Robert Rich